Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies

Panse, Jens Peter; Gonzalez Fernandez, Fernando Ataulfo; Röth, Alexander; Schrezenmeier, Hubert; Gotoh, Akihiko; Kulasekararaj, Austin G.; Cermak, Jaroslav; Stefani, Jennifer; Gentile, Brittany; Sahin, Fahri; Uguen, Marianne; Ueda, Yasutaka; Han, Bing; Straetmans, Nicole; Scheinberg, Phillip; Kyselova, Olena; Chang, Alice C.

doi:0006-5242

Information
References (0)
Discussion (0)
Files

Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies - RWTH-2025-10306

Similar records

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines